With the Chinese API Market Growing, CPhI China Assists Enterprises with Transformation, Innovation, and Comprehensive Upgrading
SHANGHAI, Dec. 13, 2018 /PRNewswire/ -- The CPhI & P-MEC China 2019 organized by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and co-organized by Shanghai UBM Sinoexpo International Exhibition Co., Ltd. will be held at Shanghai New International Expo Centre (SNIEC) on June 18-20, 2019. CPhI China will help enterprises write a new chapter for pharmaceuticals and develop new patterns of international market transformation and upgrading.
As China continues to advance from a big country in pharmaceuticals to a power in pharmaceuticals, and the global economy maintains a good trend, the main business income of API manufacturing in China has reached RMB 499.1 billion, growing by 14.68% year on year; and the export of APIs has reached USD 29.1 billion, growing by 13.7% year on year. Under the background of the new round of economic structure adjustment and supply-side reform, the proportion of import and export of western medicine preparations and biochemical drug products that are of higher additional value continues to increase in western medicine trade, showing that the transformation and upgrading of China's pharmaceutical industry has taken a big step forward. The steadily progressing achievements and the unlimited potential demonstrate that China's pharmaceutical industry is marching on a road of sustainable and healthy development.
Exhibition scale upgraded, upstream and downstream industrial chain covered
In compliance with the industry development trends, CPhI China has been constantly extending coverage of upstream and downstream industrial chain while supporting the pharmaceutical API industry over its 18 year history. It now includes 8 segments including APIs, fine chemical and intermediate, pharmaceutical excipients, preparations, contract research, biopharmaceuticals, natural extracts, and animal health & feed, and has become a second-to-none professional trade exchange event in the vertical chain of the global pharmaceutical industry.
BioPh China will be newly upgraded into bioLIVE China in 2019, to focus on exhibiting products and technologies in genetic, antibody and biological cell engineering, providing biopharmaceutical companies, new drug R&D enterprises, and professionals a unique one-stop exchange platform for pharmaceutical trade, and fostering the development of the biopharmaceutical industry. Moreover, the zones for finished dosages, pharmaceutical excipients, and animal health and feed will continue to expand in 2019, to further refine the industry chain and build an upstream-downstream integrated platform.
Leading innovation through an international vision, and gathering Chinese and overseas exhibitor groups and visitors
The 2019 exhibition will cover all 17 halls of SNIEC for the first time, creating the strongest lineup in its history and expanding the exhibition area to 200,000m2. It is expected to gather over 3,200 Chinese and overseas enterprises, and attract over 70,000 Chinese and overseas visits from 120 countries and regions. Over 100 high scale meetings and activities will be held on site concurrently with the exhibition, to present the latest development trends and advanced technologies of global pharmaceuticals.
Famous for its high internationalization, CPhI & P-MEC China has attracted international exhibitor groups from South Korea and India, as well as growing numbers of international visitors from all over the world. The 2018 exhibition attracted a total of 15,329 overseas visits, which was highly praised by exhibitors. Lin Hui, Chairman of Guangzhou Baiyunshan Chemical Pharmaceutical Factory, said, "Joining CPhI for consecutive years to meet many well-known Chinese and overseas enterprises has offered many opportunities for expanding our new market and seeking new partners and new business opportunities for cooperation. As the number of well-known Chinese and overseas enterprises that join the exhibition grows, the exhibition provides a good platform for us to display strength and expand visibility."
China Pharma Week, an unmissable annual high-end event of the pharmaceutical industry
CPhI China is an exhibition always at the forefront of the international pharmaceutical industry. The organizers will launch the third edition of the 5-day "China Pharma Week" (June 17-21) in 2019, to cover themes of Leadership, Business, Networking, Recognition, Knowledge, and Innovation of the pharmaceutical industry. The conferences will have extensive coverage, including analysis of Chinese and foreign pharmaceutical laws and regulations and new policies, analysis of markets of key export countries, and sharing of experience in overseas market development, etc.; and the events will be diversified, from the top-notch awards selection of the industry and enterprise executives networking dinner to factory visits and discovery tours. The conferences and activities will extend the grand moments of the event for "pre-exhibition" and "post-exhibition", and continue to create a quality atmosphere for people on the pharmaceutical industry chain to achieve business cooperation and negotiation, and quality interactions.
Visit the exhibition website www.cphi-china.cn/en now to register online and join the annual pharmaceutical event for pharmaceutical practitioners.
CPhI China 2019
June 18-20, 2019, SNIEC, Shanghai, China
Organizer: UBM EMEA, CCCMHPIE
Co-organizer: UBM Sinoexpo
SOURCE Shanghai UBM Sinoexpo International Exhibition Co., Ltd
Share this article